CD4 and tuberculosis: Compared with several common subunit vaccines that have entered clinical trials (H1, H56, ID93, MVA85, eras-402), M72:AS01 elicited the highest levels of Th1 cytokines and memory CD4+ T-cell responses (111), which also highlights the advantages of M72 as a novel vaccine against TB.